期刊
JOURNAL OF CYSTIC FIBROSIS
卷 14, 期 3, 页码 412-413出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jcf.2014.07.013
关键词
Rhinosinusitis; Ivacaftor; CFTR potentiator; Cystic Fibrosis; Computed Tomography
In patients with Cystic Fibrosis and a type III mutation, ivacaftor (Kalydeco (R), Vertex) can increase the opening time of the CFTR channel and improve chloride transport. Research showed significant improvement of lung function and increase in weight following ivacaftor use. However, ivacaftor showed to have adverse events on the sinonasal system as well, such as upper respiratory tract infections, nasal congestion and headaches. This case report showed a positive effect of ivacaftor on the sinonasal pathology in a 17 year old patient with CF. After 5 months of ivacaftor use, the CT-sinus showed complete resolution of the pacification of the paranasal sinuses and a decrease in symptoms of sinonasal disease. This positive effect of ivacaftor on sinonasal pathology seems promising, therefore more research is needed to evaluate the effect of ivacaftor on the upper airways in CF. (C) 2014 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据